Efficacy, safety, and predictive model of Palbociclib in the treatment of HR-positive and HER2-negative metastatic breast cancer. Wang W, Lei W, Fang Z, Jiang R, et al. BMC Cancer 2024;24:1.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang W, Lei W, Fang Z, Jiang R, et al. Efficacy, safety, and predictive model of Palbociclib in the treatment of HR-positive and HER2-negative metastatic breast cancer. BMC Cancer 2024;24:1.
PMID: 38166784